Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The corn inhibitor of activated Hageman factor: purification and properties of two recombinant forms of the protein.

Protein expression and purification·1998
Same author

Mapping quantitative trait loci for immune capacity in the pig.

Journal of immunology (Baltimore, Md. : 1950)·1998
Same author

Type of treatment and estimation of time spent on dental trauma--a longitudinal and retrospective study.

Swedish dental journal·1998
Same author

Distress level in men undergoing intracytoplasmic sperm injection versus in-vitro fertilization.

Human reproduction (Oxford, England)·1998
Same author

Genomic approaches to the improvement of disease resistance in farm animals.

Revue scientifique et technique (International Office of Epizootics)·1998
Same author

Xenoduplex analysis--a method for comparative gene mapping using hybrid panels.

Genome research·1998
Same journal

Erratum to: Is routine ureteral stenting necessary after uncomplicated ureteroscopic lithotripsy for lower ureteral stones larger than 1 cm?

Urological research·2017
Same journal

2002 30(th) Munich Endourological Symposium 10-11 October 2002.

Urological research·2014
Same journal

Ellagica acid inhibits arylamine N-acetyltransferase activity and DNA adduct formation in human bladder tumor cell lines (T24 and TSGH 8301).

Urological research·2014
Same journal

Biomolecular mechanism of urinary stone formation involving osteopontin.

Urological research·2012
Same journal

Renal tubular epithelial cell injury, apoptosis and inflammation are involved in melamine-related kidney stone formation.

Urological research·2012
Same journal

Role of 1 week of antibiotic prophylaxis before percutaneous nephrolithotomy.

Urological research·2012
See all related articles

Related Experiment Video

Updated: Jan 25, 2026

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
05:56

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting

Published on: June 21, 2024

2.0K

Chemotherapy in bladder carcinoma

F Edsmyr, L Andersson

    Urological Research
    |January 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Treatment for recurrent bladder cancer using cytostatic drugs was often ineffective for infiltrating types. However, Thiotepa and Adriamycin instillations showed promise for specific bladder conditions like papillomatosis and carcinoma in situ.

    More Related Videos

    Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
    11:02

    Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

    Published on: October 30, 2013

    21.7K
    An Orthotopic Model of Murine Bladder Cancer
    09:07

    An Orthotopic Model of Murine Bladder Cancer

    Published on: February 6, 2011

    16.5K

    Related Experiment Videos

    Last Updated: Jan 25, 2026

    Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
    05:56

    Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting

    Published on: June 21, 2024

    2.0K
    Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
    11:02

    Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

    Published on: October 30, 2013

    21.7K
    An Orthotopic Model of Murine Bladder Cancer
    09:07

    An Orthotopic Model of Murine Bladder Cancer

    Published on: February 6, 2011

    16.5K

    Area of Science:

    • Oncology
    • Urology

    Background:

    • Recurrent bladder carcinoma presents significant treatment challenges.
    • Systemic cytostatic drug efficacy is often limited in advanced bladder cancer.

    Purpose of the Study:

    • To evaluate the effectiveness of intravesical chemotherapy for recurrent bladder carcinoma.
    • To compare outcomes of different cytostatic agents for specific bladder cancer subtypes.

    Main Methods:

    • Retrospective analysis of patients with recurrent bladder carcinoma.
    • Treatment administration via intravesical instillation of Thiotepa and Adriamycin.
    • Assessment of treatment response based on clinical and pathological outcomes.

    Main Results:

    • Intravesical Thiotepa demonstrated better outcomes for bladder papillomatosis.
    • Intravesical Adriamycin showed improved results for carcinoma in situ.
    • Conventional systemic cytostatic drugs were generally unsatisfactory for infiltrating bladder carcinoma.

    Conclusions:

    • Intravesical chemotherapy, specifically Thiotepa and Adriamycin, offers a viable treatment option for select cases of recurrent bladder carcinoma.
    • Tailoring intravesical treatment to the specific histological subtype of bladder cancer is crucial for optimizing patient outcomes.